Adagene

Four Cancer Clinical Trials Advance with Blessing of FDA
BioSpace
Wed, 03/16/22 - 11:23 pm
cancer
oncology
FDA
clinical trials
Sonnet BioTherapeutics
SON-1010
solid tumors
Adagene
AD126
AIM ImmunoTech
Ampligen
pancreatic cancer
Wugen
WU-CART-007
A pair of biotechs prepares to hit Nasdaq, as total 2021 IPO raise quickly approaches $3B
Endpoints
Sat, 02/13/21 - 11:10 pm
IPOs
Adagene
Decibel Therapeutics
NexImmune
Protagenic
IPO tracker: 2021 gets started with a flurry of new offerings
Endpoints
Mon, 01/25/21 - 10:43 am
IPOs
Sana Biotechnology
Sensei Biotherapeutics
Bolt Biotherapeutics
Immunocore
Terns Pharmaceuticals
Pharvaris
Vor Biopharma
Adagene
NexImmune
Biophytis
Gracell Biotechnologies
Cullinan Oncology